There’s now a better way for providers to more accurately and completely identify, diagnose and monitor patients' mental health to deliver better outcomes and improve quality measures.
nView’s evidence-based behavioral health solutions make it easier for healthcare providers to assess the complete mental health needs of their patients — not just depression — all from a single solution. The PHQ-9 can't do that.
|
MORE COMPREHENSIVE Unlike the PHQ-9, the GAD-7, or other widely used depression and anxiety questionnaires, the nView solution screens and provides a structured interview to help providers accurately identify the 24 most common DSM-5 pediatric conditions, 17 most common adult conditions, and other related conditions. |
FULLY INDEPENDENT Unlike the PHQ-9 that is owned by an anti-depression drug manufacturer, nView’s behavioral health solutions were independently developed by trained psychiatrists with no connections to manufacturers, removing potential bias from the screening and interviewing solutions. |
|
STRUCTURED INTERVIEW While other solutions are simple questionnaires that identify symptoms of depression or anxiety, nView structured interviews help providers more accurately identify and treat mental health disorders. |
MONITORING CAPABILITIES To help monitor patient progress and support measurement-based care initiatives, nView monitoring solutions allow providers to track patient progress and outcomes over time. |
|
REIMBURSABLE nView screeners, assessments and monitors can be reimbursed by virtually all major payers. |
CLINICAL STANDARD nView solutions have been cited in more than 20,000 publications and have been used in clinical studies worldwide for the past 25+ years. |